Based on previous cross-sectional findings, we hypothesized that weight loss could improve several hemostatic factors associated with cardiovascular disease. In a randomized controlled trial, moderately overweight men and women were assigned to one of four weight loss treatment groups or to a control group. Measurements of plasminogen activator inhibitor-1 (PAI-1) antigen, tissue-type plasminogen activator (t-PA) antigen, D-dimer antigen, factor VII activity, flbrinogen, and protein C antigen were made at baseline and after 6 months in 90 men and 88 women. Net treatment weight loss was 9.4 kg in men and 7.4 kg in women. There was no net change (p>0.05) in D-dimer, fibrinogen, or protein C with weight loss. Significant (p<0.05) decreases were observed in the combined treatment groups compared with the control group for mean PAI-1 (31% decline), t-PA antigen (24% decline), and factor VII (11% decline). Decreases in these hemostatic variables were correlated with the amount of weight lost and the degree that plasma triglycerides declined; these correlations were stronger in men than women. These findings suggest that weight loss can improve abnormalities in hemostatic factors associated with obesity. ( role in the development of cardiovascular disease. In prospective studies fibrinogen and factor VII have been positively associated with coronary heart disease incidence. 1 -2 A deficiency of protein C, an inhibitor of factors V and VIII, increases the risk of thromboembolic disease.
ndogenous hemostatic factors play an important role in the development of cardiovascular disease. In prospective studies fibrinogen and factor VII have been positively associated with coronary heart disease incidence. 1 -2 A deficiency of protein C, an inhibitor of factors V and VIII, increases the risk of thromboembolic disease. 3 Plasminogen activator inhibitor-1 (PAI-1), an inhibitor of tissue-type plasminogen activator (t-PA) and, hence, an inhibitor of fibrinolysis, has been positivery associated with myocardial infarction occurrence 4 and recurrence. 5 However, in another study t-PA antigen, but not PAI-1, was associated with myocardial infarction recurrence. 6 Obesity, especially abdominal obesity, is associated with perturbations of the hemostatic system. 7 " 16 Obesity-related hypertriglyceridemia and hyperinsulinemia contribute to these perturbations. ' 7 Increased coagula-local newspaper advertisements and screened for eligibility by interview. Eligible subjects were 25-44 years old, 14-23 kg over ideal weight for height (defined as the midpoint of the 1983 Metropolitan Life Insurance tables), willing to be randomized to any of the five study groups, and willing to participate in future exams. Exclusions were made on the basis of regular tobacco use, pregnancy or planned pregnancy in the next 18 months, history of major disease (i.e., heart disease, diabetes, cancer, or psychosis), regular use of any prescription medications, or living more than 30 minutes from the clinic. A total of 202 participants (101 men and 101 women) were ultimately selected for the twosite trial.
Treatment TRIM participants were randomized to one of five groups: 1) a standard behavioral program, 2) a standard program with financial incentives, 3) a standard program with provision of food, 4) a standard program with both financial incentives and food provision, and 5) a control group. The control group received no dietary counseling but were given handouts describing and recommending the American Heart Association Phase 1 diet. The four treatment groups were given a calorierestricted diet intended to produce a weight loss of approximately 2 pounds per week. If participants achieved their ideal body weight, the calorie intake was adjusted to maintain ideal weight. Calorie restriction was accomplished by encouraging a reduction in the intake of total fat and sugar and an increase in the intake of complex carbohydrates, conforming with the American Heart Association Phase 1 dietary guidelines. Light-to-moderate exercise, specifically walking or bicycling, was prescribed to contribute to a calorie deficit. The weight loss intervention took place over a 6-month period.
Measurements
Physiological measurements were taken before the onset of treatment during January and February 1990 and 6 months later during July and August 1990. Participants were asked to fast for 12 hours before their examinations, which took place almost without exception between 7:15 AM and 10:15 AM. After participants had put on a hospital gown and removed their shoes, a certified technician measured height to the nearest centimeter (using a vertically mounted rule) and weight to the nearest pound (using a balance-beam scale). Body mass index (BMI) was calculated by dividing weight in kilograms by height in meters squared. The circumferences of the waist (umbilical level) and hips (maximal protrusion) were measured to the nearest centimeter with the participant standing erectly. The waist-to-hip ratio was calculated as a measure of fat distribution.
Following a 5-minute rest, a certified technician measured systolic and diastolic blood pressures in the right arm of seated participants. Two measurements were taken with a random-zero sphygmomanometer, and their average was used in analysis.
Leisure-time physical activity was assessed over the prior week and the prior 6 months using a modification of the questionnaire developed by Paflfenbarger et al. 33 A physical activity score was derived as kilocalories expended per week in walking, leisure activity, and stair climbing.
Blood samples were collected with minimal tourniquet use from seated participants at least 10 minutes after blood pressure measurement. Fasting blood lipid samples were collected into EDTA plasma tubes. Fasting hemostasis specimens were collected into 4.5-ml vacuum tubes containing 0.5 ml of 3.8% sodium citrate anticoagulant. Insulin specimens were collected into glass tubes during fasting and 2 hours after oral intake of 75 g glucose. All blood samples were processed immediately in a nonrefrigerated centrifuge at 3,000g for 10 minutes. EDTA plasma and serum aliquots were refrigerated and frozen at -20°C. Plasma total cholesterol and triglycerides were measured within a few weeks by enzymic methods at the Nutrition Core Laboratory, Department of Epidemiology, University of Pittsburgh. Plasma insulin measurements were made within 2 years by the University of Pittsburgh Diabetes Research Center using a modification of the immunoassay techniques of Herbert et al. 34 Hemostatic factor aliquots were stored at -70°C so that baseline and follow-up samples could be analyzed at the same time.
Hemostasis measurements were made, blinded, at the University of Texas at Houston. PAI-1 antigen was measured by a double-antibody enzyme immunoassay (ELA) (American Diagnostica, Inc., Greenwich, Conn.). The assay detects active and latent inactive forms of PAI-1, although t-PA-PAI-1 and urokinase-type PA-PAI-1 complexes are recovered with low efficiency. The detection level is < 1 ng/ml PAI-1. t-PA antigen was assayed by an EIA kit from Diagnostica Stago (American Bioproducts Co., Parsippany, N.J.). This assay detects total circulating t-PA (free and complexed with PAI-1), including both the single-chained and doublechained structures. D-Dimer antigen was measured by an EIA kit from Diagnostica Stago. Fibrinogen was measured by the thrombin-time titration method originally described by Gauss. 35 Thrombin and the calibration reference (Fibriquick) for the fibrinogen assay were obtained from General Diagnostics (Organon Technika Co., Oklahoma City, Okla.). Factor VII activity was measured by determining the ability of the testing sample to correct the clotting time of human factor Vll-deficient plasma obtained from Pacific Hemostasis (Vehtura, Calif.). The plasma factor VII level was determined by relating the clotting time to a calibration curve constructed with each assay. Protein C antigen was measured by an EIA technique using a kit from Diagnostica Stago. Different batches of Universal Coagulation Reference Plasma (Thromboscreen, Pacific Hemostasis) were used for calibration and quality control of hemostasis assays. The method coefficients of variation for this laboratory are 8% for PAI-1, 11% for t-PA, 6% for D-dimer, 7% for fibrinogen, 9% for factor VII, and 10% for protein C.
Statistical Analysis
Of the original 202 participants, 24 were excluded (22 did not return for the second examination, and the technician was unable to draw blood from two). The 22 noncompleters of the second examination were compared with the 178 completers on 14 variables measured at baseline. The only detectable differences (/?<0.05) were that, on average, noncompleters were about 4 years younger, had slightly lower blood pressures, and had triglyceride levels lower by 32 mg/dl than the completers.
Sex-specific analyses were performed because evidence suggests weight loss may affect physiological parameters differently in men and women.
3236 - 37 The characteristics of participants were described by presenting sex-specific mean values and standard deviations. Several hemostatic variables had somewhat skewed distributions. Analyses using logarithmic transformations yielded similar results to untransformed analyses, so the latter are presented. Pearson correlation coefficients were computed to measure associations between variables at both baseline and 6 months, as well as associations between changes from baseline to 6 months. Change variables were computed as 6-month follow-up values minus baseline values. Changes across the four active treatment groups were similar, so we assessed differences by comparing the combined treatments versus control using analysis of variance and an orthogonal contrast. Sex-specific multiple linear regression models were also used to detect the independence of associations.
Results

Descriptive Information
Sex-specific baseline characteristics of participants are shown in Table 1 . The mean±SD age was 38 ±6 years. Participants were moderately overweight, with the average BMI being 31 kg/m 2 . Compared with women, men had higher average PAI-1 and t-PA antigen levels, lower D-dimer and fibrinogen levels, and equivalent factor VII and protein C levels.
Baseline PAI-1 and t-PA antigen levels were strongly correlated with each other in both men (r=0.63) and women (r=0.51). Baseline fibrinogen and D-dimer were also correlated in men (r=0.40) and women (r=0.34). Baseline factor VII and protein C were only weakly correlated with each other, but at follow-up were correlated for women (r=0.49) and for men (r=0.52). Correlations among the other hemostatic factors were weaker (|r|s<0.3) and not always consistent for both sexes or for both baseline and follow-up.
Cross-sectional Associations
As Table 2 shows, in men at baseline and follow-up BMI and waist-to-hip ratio were correlated positively with t-PA antigen, PAI-1 antigen, and factor VII (ranging from r=0.21 to r=0.56). In women, BMI and waistto-hip ratio were not correlated with t-PA antigen, PAI-1, or factor VII at baseline but were correlated at follow-up (from r=0.15 to r=0.35).
t-PA antigen, PAI-1, and factor VII ( Table 2) were correlated strongly and positively with plasma triglyceride level (from r=0.22 to r=0.53). With the exception of factor VII in men, these three hemostatic factors were •(•Characteristics at baseline, unless noted. •Treatment groups 1 to 4 combined versus control group.
correlated positively with insulin values, both fasting and at 2 hours; correlations with insulin were somewhat stronger at follow-up (from r=0.20 to r=0.60, data not shown) than at baseline. t-PA, PAI-1, and factor VII in men were also correlated positively with plasma cholesterol and systolic blood pressure levels and negatively with exercise. In women, these correlations with plasma cholesterol and blood pressure were not as strong as in men, and there were no correlations of consequence with exercise.
In men, fibrinogen and D-dimer showed no significant cross-sectional association with any anthropometric or other characteristic. This was also true in women, except that fibrinogen was correlated with BMI (r=0.24) and plasma cholesterol (r=0.17). Protein C was correlated with plasma cholesterol (r=0.32 in men, r=0.22 in women) and triglycerides (r=0.12 in men, r=0.26 in women).
Associations With Weight Change
All four treatment groups lost weight over the 6 months, ranging from 7.8 kg to 11.4 kg. Food records showed that, in addition to caloric deficits, the four treatment groups equivalently (p>0.05) decreased the percentage of calories from fat; the net reduction compared with the control group ranged from 0.2% to 4.4%. Because both these and the hemostatic factor changes were equivalent across the four treatment groups, they were combined for further analyses.
Weight decreased approximately 8.4 kg more in the combined treatment group than in the control group (Table 3) , Most of the weight was lost within the first 5 months; on average, < 1 kg was lost in the month before the 6-month follow-up assessment. For men, the net treatment weight loss was 9.4 kg and for women, 7.4 kg. Simultaneously, triglycerides, PAI-1, t-PA antigen, and factor VII decreased in each treatment group but increased in the control group (/?< 0.005 for treatment versus control). In comparison with the baseline mean values (Table 1) , these treatment declines were 15% for triglycerides, 31% for PAI-1, 24% for t-PA antigen, and 11% for factor VII. In comparison with the baseline standard deviations, these declines amounted to 25%, 41%, 57%, and 55% of their standard deviations, respectively. There were no net changes in fibrinogen, D-dimer, or protein C in relation to weight loss. Fasting and 2'hour insulin values decreased in the treatment groups, but these were not statistically significant changes in comparison with the control group.
Analyzing all subjects together, declines in PAI-1, t-PA antigen, and factor VII were correlated with declines in most anthropometric variables (from r=0.18 to r=*0.53 for most associations; Table 4 ). These correlations were stronger for men than women, especially for factor VII. Figure 1 depicts the dose-response relations of these three factors with the percentage of weight lost.
Changes in PAI-1, t-PA antigen, and factor VII were highly correlated with change in triglycerides (from r=0.23 to r=0.60), with one exception (PAI-1 in women). Changes in PAI-1, t-PA antigen, and factor VII were also correlated positively with changes in plasma cholesterol and systolic blood pressure, more strongly in men than women. Changes in these three hemostatic factors were not strongly correlated with changes in fasting or 2-hour insulin values, nor were they correlated with changes in the proportional contribution of energy from total fat or various fatty acids (dietary data not shown).
Multivariate Considerations
To determine whether the association of changes in PAI-1, t-PA antigen, and factor VII with weight change could potentially be explained by concomitant changes in triglycerides or insulin, we ran several sex-specific multiple linear regression analyses. The dependent variable was change in one of the three hemostatic factors, and the independent variables were various combinations of weight change, triglyceride change, and 2-hour insulin change. In the regression analysis each 10 kg of weight loss was associated univariately with decreases in Mehrabian et al 22 Gris et al 23 Baron et al 24 Parenti et al 25 Ernst et al 26 Ernst and Matrai 27 Gelmini et al 28 Meade et al29 PAI-1 of 12.8 ng/ml in men and 7.8 ng/ml in women (both />:s0.01); terms for triglyceride change and/or 2-hour insulin change had no impact on these estimates, and neither was statistically significant in any multivariate model that included weight change. Each 10 kg of weight loss was also associated unrvariately with decreases in t-PA antigen of 2.3 ng/ml in men and 1.7 ng/ml in women (both p< 0.01); however, terms added for trigryceride change were significant (p<0.01) and reduced somewhat the regression coefficients for weight loss, suggesting that triglyceride changes may explain part of the weight-loss effect. Insulin change had little independent impact on t-PA antigen. Similarly, a 10-kg weight loss was associated univariatery with a decrease of factor VII by 7.3 percentage points in men (p=0.03) but only by 1.8 percentage points in women (/?=0.66); terms for triglyceride change could explain essentially all of the lowering of factor VII with weight loss, but insulin change had no independent impact.
Discussion
The most important findings of this trial were that plasma levels of PAI-1, t-PA antigen, and factor VII were positively associated with obesity and could be reduced with weight loss. In contrast, levels of fibrinogen, r>dimer, and protein C exhibited little relation to excess weight or weight loss. Some strengths of this study are that 1) it examined a large sample of moderately overweight men and women, a group that comprises a large proportion of the adult population; 2) its subjects achieved sizable weight losses over a sustained period; and 3) its results were generally consistent both cross-sectionally and in the longitudinal trial. Previous trials, although consistent, have been smaller, shorter, and often without control groups (Table 5) .
We chose to assess PAI-1 and t-PA antigen as indicators of impaired fibrinolysis because they are relatively easily measured and have been previously correlated with obesity. 23 PAI-1, which is present in platelets and plasma, is synthesized and released from the liver and endothelial cells and inhibits t-PA activity by binding to t-PA antigen. 1 7 -30 -31 Both t-PA and PAI-1 are cleared by the liver. t-PA antigen typically rises when PAI-1 inhibition rises, so that high levels of either factor reflect reduced fibrinolysis. 30 -31 This covariation partly accounts for the high correlation observed between these two factors, but the PAI-1 assay we used also measures t-PA-PAI-1 complexes to some degree. Thus, the fall in both factors with weight loss probably reflects a single phenomenon of improved fibrinolysis.
Recent evidence suggests that triglyceride alters PAI-1 production by endothelial cells in vitro. 17 Insulin increases PAI-1 synthesis by hepatocytes but not endothelial cells. 17 The effect of weight loss on improving PAI-1 and t-PA antigen levels, therefore, was hypothesized to be the result of simultaneous alterations of plasma triglycerides or insulin. Indeed, the univariate correlations of changes in PAI-1 and t-PA antigen with changes in triglycerides were significant. However, in statistical models, changes in PAI-1 with weight loss appeared to be unexplainable by changes in triglycerides or 2-hour insulin. In contrast, changes in t-PA antigen with weight loss appeared to be partly explainable by triglyceride changes.
The connection between weight loss and factor VII may also be plasma triglycerides. The univariate correlation between factor VII change and triglyceride change was approximately 0.35 for both men and women, and in multivariate models triglyceride change seemed to account for much of the weight-loss effect. Other studies have reported strong positive associations between factor VII and lipoproteins rich in triglycerides, presumably because these lipoproteins activate factor VII. 38 - 40 Moreover, feeding dietary fat increases factor VII levels. 41 The correlations between weight loss and PAI-1, t-PA antigen, and factor VII were generally greater in men than women. The reasons for this finding are uncertain. It is, however, consistent with the literature, 32 -36 - 37 suggesting that weight loss has a smaller effect on other physiological parameters, such as high density lipoprotein cholesterol, in women than in men. Part of the explanation may be that obesity in men is more likely to be of visceral origin than in women. Alternatively, variability may have been greater for women than men because estrogen can affect hemostatic factors, 42 -43 and no standardization was made for menstrual cycle. D-Dimer may have shown no relation to weight or weight loss because it is a marker of the deposition and lysis of fibrin, which may not be actively occurring in otherwise healthy subjects. Fibrinogen and protein C actually decreased modestly in the four treatment groups but also decreased in the control group, for no overall effect attributable to weight loss. Declines in fibrinogen and protein C between baseline (winter) and follow-up (summer) could be due to reported seasonal effects. 44 Declines are unlikely to have been due to storage (specimens were kept at -70°C) or to laboratory drift (baseline and follow-up specimens were analyzed together). Regardless of the cause, these findings emphasize the necessity of a control group for properly interpreting changes in hemostatic factors with weight loss.
Plasma cholesterol and blood pressure, to varying degrees in men and women, were also associated with PAI-1, t-PA antigen, and factor VII at baseline, and changes in these factors were correlated. These correlations may not be causal; rather, they may be indirect consequences of weight loss. However, low density lipoprotein has been reported to stimulate hepatocyte synthesis of PAI-1 in vitro, 17 and a correlation between factor VII rise and low density lipoprotein cholesterol rise during fat feeding has also been reported. 41 Correlations between hypertension and fibrinolysis have been reported, 45 but to our knowledge a causal explanation has not been reported.
Some limitations of this study warrant consideration. First, we had only one baseline and one follow-up measurement of most factors. Random within-person fluctuations or laboratory error based on single measurements of hemostatic factors 46 would tend to yield weaker observed associations than may truly exist. Furthermore, the high variability inherent in measurements of triglycerides and insulin means that their contributions to hemostatic factor change also were underestimated. Second, our samples were centrifuged at room temperature. Recent evidence 47 suggests that PAI-1 levels may be altered somewhat if they are not handled at low temperatures with added antiplatelet agents. However, even if handling effects occurred in this study, they should be equal across treatment groups and, therefore, not affect the overall conclusions. Third, the hypocaloric diet involved a reduction in fat and its replacement with carbohydrate. It may be that a change in dietary composition, as well as a reduction of caloric intake, contributed to the hemostatic factor changes; however, changes in fat estimated from food records were not correlated with hemostatic factor changes. The modest increase in walking or bicycling is less likely to be a contributor as shown by the low correlation of reported exercise with hemostatic factors. Finally, although this study was longer than most previous investigations and the weights of most participants had stabilized for a month before follow-up assessments, we do not know whether hemostatic factor improvements persisted over the long term.
Altered hemostasis may be one mechanism by which obesity, particularly abdominal obesity, conveys a higher coronary heart disease risk. The observed relative differences in mean PAI-1 of 31%, mean t-PA antigen of 24%, and mean factor VII of 11% associated with 8.4 kg of weight loss are of about the same magnitude as reported for the occurrence and recurrence of coronary heart disease events.
14 -6 For example, young survivors of myocardial infarction had 18% higher t-PA antigen and 113% higher PAI-1 than did control subjects, 4 and patients in whom myocardial infarction recurred had 61% higher PAJ-1. 5 Furthermore, based on the Northwick Park Heart Study results, the observed factor VII reduction might translate to a 29% lower risk of coronary heart disease in 5 years. 1 The finding that weight loss can improve certain hemostatic factors thus offers further rationale for the avoidance of obesity.
